-
Ahn JS, Whitby MC, 2003: The role of the SAP motif in promoting Holliday junction binding and resolution by SpCCE1[J]. J Biol Chem, 278, 29121-29129. doi: 10.1074/jbc.M302314200
-
Alexandersen S, Zhang Z, Donaldson AI, Garland AJ, 2003: The pathogenesis and diagnosis of foot-and-mouth disease[J]. J Comp Pathol, 129, 1-36. doi: 10.1016/S0021-9975(03)00041-0
-
Aravind L, Koonin EV, 2000: SAP-a putative DNA-binding motif involved in chromosomal organization[J]. Trends Biochem Sci, 25, 112-114. doi: 10.1016/S0968-0004(99)01537-6
-
Audic S, Claverie JM, 1997: The significance of digital gene expression profiles[J]. Genome Res, 7, 986-995. doi: 10.1101/gr.7.10.986
-
Barasa M, Catley A, Machuchu D, Laqua H, Puot E, Tap KD, Ikiror D, 2008: Foot-and-mouth disease vaccination in South Sudan: benefit-cost analysis and livelihoods impact[J]. Transbound Emerg Dis, 55, 339-351. doi: 10.1111/jva.2008.55.issue-8
-
Bohm F, Kappes F, Scholten I, Richter N, Matsuo H, Knippers R, Waldmann T, 2005: The SAF-box domain of chromatin protein DEK[J]. Nucleic Acids Res, 33, 1101-1110. doi: 10.1093/nar/gki258
-
Cheyssac C, Dina C, Lepretre F, Vasseur-Delannoy V, Dechaume A, Lobbens S, Balkau B, Ruiz J, Charpentier G, Pattou F, Joly E, Prentki M, Hansen T, Pedersen O, Vaxillaire M, Froguel P, 2006: EIF4A2 is a positional candidate gene at the 3q27 locus linked to type 2 diabetes in French families[J]. Diabetes, 55, 1171-1176. doi: 10.2337/diabetes.55.04.06.db05-1298
-
Chinsangaram J, Mason PW, Grubman MJ, 1998: Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus[J]. Vaccine, 16, 1516-1522. doi: 10.1016/S0264-410X(98)00029-2
-
Clarke BE, Sangar DV, Burroughs JN, Newton SE, Carroll AR, Rowlands DJ, 1985: Two initiation sites for foot-and-mouth disease virus polyprotein in vivo[J]. J Gen Virol, 66, 2615-2626. doi: 10.1099/0022-1317-66-12-2615
-
de Los Santos T, Diaz-San Segundo F, Grubman MJ, 2007: Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection[J]. J Virol, 81, 12803-12815. doi: 10.1128/JVI.01467-07
-
de Los Santos T, Diaz-San Segundo F, Zhu J, Koster M, Dias CC, Grubman MJ, 2009: A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function[J]. J Virol, 83, 1800-1810. doi: 10.1128/JVI.02112-08
-
de Los ST, de Avila BS, Weiblen R, Grubman MJ, 2006: The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response[J]. J Virol, 80, 1906-1914. doi: 10.1128/JVI.80.4.1906-1914.2006
-
Devaney MA, Vakharia VN, Lloyd RE, Ehrenfeld E, Grubman MJ, 1988: Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex[J]. J Virol, 62, 4407-4409.
-
Diaz-San Segundo F, Weiss M, Perez-Martin E, Dias CC, Grubman MJ, de Los Santos T, 2012: Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease[J]. J Virol, 86, 1316-1327. doi: 10.1128/JVI.05941-11
-
Dienz O, Rud JG, Eaton SM, Lanthier PA, Burg E, Drew A, Bunn J, Suratt BT, Haynes L, Rincon M, 2012: Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung[J]. Mucosal Immunol, 5, 258-266. doi: 10.1038/mi.2012.2
-
ElAntak L, Tzakos AG, Locker N, Lukavsky PJ, 2007: Structure of eIF3b RNA recognition motif and its interaction with eIF3j: structural insights into the recruitment of eIF3b to the 40 S ribosomal subunit[J]. J Biol Chem, 282, 8165-8174. doi: 10.1074/jbc.M610860200
-
Grubman MJ, Moraes MP, Diaz-San Segundo F, Pena L, de Los Santos T, 2008: Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen[J]. FEMS Immunol Med Microbiol, 53, 8-17. doi: 10.1111/fim.2008.53.issue-1
-
Han H, Xue-Franzen Y, Miao X, Nagy E, Li N, Xu D, Sjoberg J, Bjorkholm M, Claesson HE, 2015: Early growth response gene (EGR)-1 regulates leukotriene D4-induced cytokine transcription in Hodgkin lymphoma cells[J]. Prostaglandins Other Lipid Mediat, 121, 122-130. doi: 10.1016/j.prostaglandins.2015.06.004
-
Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, Yamanishi Y, 2008: KEGG for linking genomes to life and the environment[J]. Nucleic Acids Res, 36, D480-D484.
-
Kipp M, Gohring F, Ostendorp T, van Drunen CM, van Driel R, Przybylski M, Fackelmayer FO, 2000: SAF-Box, a conserved protein domain that specifically recognizes scaffold attachment region DNA[J]. Mol Cell Biol, 20, 7480-7489. doi: 10.1128/MCB.20.20.7480-7489.2000
-
Kirchweger R, Ziegler E, Lamphear BJ, Waters D, Liebig HD, Sommergruber W, Sobrino F, Hohenadl C, Blaas D, Rhoads RE, Et A, 1994: Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma[J]. J Virol, 68, 5677-5684.
-
Kyono K, Miyashiro M, Taguchi I, 2002: Human eukaryotic initiation factor 4AⅡ associates with hepatitis C virus NS5B protein in vitro[J]. Biochem Biophys Res Commun, 292, 659-666. doi: 10.1006/bbrc.2002.6702
-
Li R, Li Y, Kristiansen K, Wang J, 2008: SOAP: short oligonucleotide alignment program[J]. Bioinformatics, 24, 713-714. doi: 10.1093/bioinformatics/btn025
-
Medina M, Domingo E, Brangwyn JK, Belsham GJ, 1993: The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities[J]. Virology, 194, 355-359. doi: 10.1006/viro.1993.1267
-
Meijer HA, Kong YW, Lu WT, Wilczynska A, Spriggs RV, Robinson SW, Godfrey JD, Willis AE, Bushell M, 2013: Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation[J]. Science, 340, 82-85. doi: 10.1126/science.1231197
-
Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B, 2008: Mapping and quantifying mammalian transcriptomes by RNA-Seq[J]. Nat Methods, 5, 621-628. doi: 10.1038/nmeth.1226
-
Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K, 1999: The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway[J]. Nature, 398, 252-256. doi: 10.1038/18465
-
Pega J, Bucafusco D, Di Giacomo S, Schammas JM, Malacari D, Capozzo AV, Arzt J, Perez-Beascoechea C, Maradei E, Rodriguez LL, Borca MV, Perez-Filgueira M, 2013: Early adaptive immune responses in the respiratory tract of foot-and-mouth disease virus-infected cattle[J]. J Virol, 87, 2489-2495. doi: 10.1128/JVI.02879-12
-
Perry BD, Rich KM, 2007: Poverty impacts of foot-and-mouth disease and the poverty reduction implications of its control[J]. Vet Rec, 160, 238-241. doi: 10.1136/vr.160.7.238
-
Piccone ME, Rieder E, Mason PW, Grubman MJ, 1995: The foot-and-mouth disease virus leader proteinase gene is not required for viral replication[J]. J Virol, 69, 5376-5382.
-
Piccone ME, Zellner M, Kumosinski TF, Mason PW, Grubman MJ, 1995: Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus[J]. J Virol, 69, 4950-4956.
-
Racaniello VR. 2007. Picornaviridae: The Viruses and Their Replication. In: Fields virology (5th ed). Philadelphia: Lippin-cott-Raven, pp. 795–948.
-
Reed LJ, Muench H, 1938: A simple method of estimating fifty percent endpoints[J]. American journal of epidemiology, 27, 493-497. doi: 10.1093/oxfordjournals.aje.a118408
-
Rufael T, Catley A, Bogale A, Sahle M, Shiferaw Y, 2008: Foot and mouth disease in the Borana pastoral system, southern Ethiopia and implications for livelihoods and international trade[J]. Trop Anim Health Prod, 40, 29-38. doi: 10.1007/s11250-007-9049-6
-
Ruggli N, Tratschin JD, Schweizer M, McCullough KC, Hofmann MA, Summerfield A, 2003: Classical swine fever virus interferes with cellular antiviral defense: evidence for a novel function of N(pro)[J]. J Virol, 77, 7645-7654. doi: 10.1128/JVI.77.13.7645-7654.2003
-
Unbehaun A, Marintchev A, Lomakin IB, Didenko T, Wagner G, Hellen CU, Pestova TV, 2007: Position of eukaryotic initiation factor eIF5B on the 80S ribosome mapped by directed hydroxyl radical probing[J]. EMBO J, 26, 3109-3123. doi: 10.1038/sj.emboj.7601751
-
Wang D, Fang L, Luo R, Ye R, Fang Y, Xie L, Chen H, Xiao S, 2010: Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type Ⅰ interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels[J]. Biochem Biophys Res Commun, 399, 72-78. doi: 10.1016/j.bbrc.2010.07.044
-
Yamazaki S, Muta T, Takeshige K, 2001: A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei[J]. J Biol Chem, 276, 27657-27662. doi: 10.1074/jbc.M103426200
-
Zheng H, Guo J, Jin Y, Yang F, He J, Lv L, Zhang K, Wu Q, Liu X, Cai X, 2013: Engineering foot-and-mouth disease viruses with improved growth properties for vaccine development[J]. PLoS One, 8, e55228-. doi: 10.1371/journal.pone.0055228
-
Zhu J, Weiss M, Grubman MJ, de Los Santos T, 2010: Differential gene expression in bovine cells infected with wild type and leaderless foot-and-mouth disease virus[J]. Virology, 404, 32-40. doi: 10.1016/j.virol.2010.04.021